Clinical Trial Update: Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma [Phase 3]

View source ↗

Summary

Phase 3 trial update for Percutaneous Hepatic Perfusion in hepatic-dominant ocular melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Ocular Melanoma

Snippet

Sponsor: Delcath Systems Inc. | Conditions: Melanoma, Ocular | Phase 3 | Status: COMPLETED